News | Brachytherapy Systems, Women's Healthcare | April 20, 2016

Clinical Data Validates Savi Scout Breast Localization and Surgical Guidance System

Results presented at SBI/ACR Breast Imaging Symposium demonstrate high rates of clinical efficacy, intraoperative retrieval and surgical success rates

April 20, 2016 — Cianna Medical Inc. announced new clinical data evaluating the Savi Scout breast localization and surgical guidance system. Results demonstrating high rates of clinical efficacy, intra-operative retrieval and surgical success rates were presented in an electronic poster session at the Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 7-10.

Savi Scout, a U.S. Food and Drug Administration (FDA)-cleared tool for localizing and directing the removal of non-palpable breast lesions, became available in late 2015.

Results from the investigator-initiated trial of 154 patients demonstrated a 100 percent surgical success rate using Scout, with a low re-excision rate that is in line with rates reported for intraoperative ultrasound. In all cases where localization was performed and data are complete, targeted lesions and reflectors were successfully removed without any observed reflector migration.

“These data confirm previous findings demonstrating that real-time surgical guidance with Scout is a clinically reproducible, safe and effective technique for directing the removal of non-palpable breast lesions with no wires or radioactive materials,” said Jiyon Lee, M.D., a presenting study investigator and assistant professor in the Department of Radiology at NYU Langone Medical Center. 

Hildegard Toth, M.D., study co-investigator and associate professor in the Department of Radiology at NYU Langone, added, “In our studies, Scout demonstrated an additional benefit of decoupling the localization and surgical procedures, which may result in improved patient scheduling and work flow.”

The study also examined clinician and patient satisfaction with Scout. Radiologists favorably rated the overall patient experience at 4.1 on a scale of 1-5, where 3 was seen as Scout having equal favorability to wire localization. Using the same scale, surgeons favorably rated ease of localization at 3.9 and ability to start cases earlier at 4.9. Post-procedural survey data indicated that 97 percent of patients would recommend Scout to other patients.

The study was conducted at 11 sites, with 17 surgeons and 24 radiologists contributing. Participating centers include: University of South Florida Breast Health, Nashville Breast Center, Baylor Regional Medical at Plano, Cancer Centers of Colorado, Hackensack University Medical Center, UC Irvine Health Pacific Breast Care Center, Medical Center of Plano Complete Breast Care, Morton Plant Mease Hospital, New York University Langone Medical Center, Pink Lotus Breast Center and Texas Breast Specialists.

For more information: www.ciannamedical.com

Related Content

breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Overlay Init